Resources
Explore our growing body of resources and research from across the women’s health innovation ecosystem.
Explore
2024
A review on critical appraisal and pathogenesis of polycystic ovarian syndrome
Hajam et al.
Reviews data on the pathogenesis, diagnostic criteria, and multifactorial causes of polycystic ovarian syndrome to inform research and management strategies.
2024
Antiretrovirals in Pregnancy Research Toolkit
World Health Organization
Provides guidance and resources to support inclusion of pregnant and breastfeeding populations in HIV, hepatitis, and STI research, focusing on ethics, study design, and data collection.
2024
B-Cell Receptor Repertoire: Recent Advances in Autoimmune Diseases
Wang et al.
Summarizes mechanisms and analytical methods for B-cell receptor repertoire diversity and reviews recent research on BCR repertoire in major autoimmune diseases.
2024
Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis Comparing a Short Course of Treatment With the Current South African Standard of Care.
ClinicalTrials.gov
Provides information on a clinical trial to compare the efficacy and safety of a Study Strategy consisting of 6 months of bedaquiline (BDQ), delamanid (DLM), and linezolid (LNZ), with levofloxacin (LVX) and clofazimine (CFZ) compared to the current South African Standard of Care (Control Strategy) for 9 months for the treatment of rifampicin resistant (RR-TB) Tuberculosis.
2024
Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021
GBD 2021 Forecasting Collaborators
Provides forecasts and scenario analyses of global disease burden, life expectancy, and risk factor impacts for 204 countries and territories to 2050 to support health policy planning.
2004
Disparities in Infectious Diseases Among Women in Developing Countries
Rashid, J. et al.
Summarizes disparities in infectious disease burden among women in developing countries, highlighting contributing factors and barriers to healthcare access and treatment adherence.
2024
DNA-sensing pathways in health, autoinflammatory and autoimmune diseases
Dong & Fitzgerald
Summarizes DNA-sensing pathways, their regulation, roles in host defense, and how their dysregulation contributes to autoinflammatory and autoimmune diseases, including therapeutic strategies.
2024
Economic Burden Of Community-Acquired Antibiotic-resistant Urinary Tract Infections: Systematic Review And Meta-analysis
Zhu et al.
Synthesizes evidence on the economic, clinical, and health system burden of antibiotic-resistant community-acquired urinary tract infections to inform resource prioritization and intervention evaluation.
2022
Effect of Gender on Clinical Presentation Of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection
Humayun, M. et al.
Provides data on gender differences in TB incidence, clinical presentation, and TB-HIV coinfection in Harare, Zimbabwe, to inform targeted interventions.
2024
Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis
Abara et al.
Summarizes published data on MenB-4C vaccine effectiveness against gonorrhea, including pooled estimates, duration of protection, and implications for vaccine development.
2006
Emerging Infections and Pregnancy
Jamieson, D. J. et al.
Summarizes how pregnancy alters immune response, increasing susceptibility and severity of emerging infectious diseases, to inform clinical and public health planning.
2006
Emerging Infectious Determinants of Chronic Diseases
O’Connor, S. M. et al.
Summarizes evidence linking infectious agents to chronic diseases, outlines mechanisms involved, and highlights implications for prevention and public health research.
Funding Opportunities
Curated global opportunities relevant to women’s health outcomes.
This list is not meant to be comprehensive — reach out if you are aware of relevant opportunities we should add. Updated every two weeks.
| Funder | Opportunity | Type | Focus | Deadline ↕ |
|---|---|---|---|---|
| Loading opportunities... | ||||
We’d love to hear from you.